International Conference on

Advanced Clinical Trials and Clinical Research

Clinical Trials 2019

Theme: Integrating precision in methodology, design and analysis of advanced clinical trials

International Conference on Advanced Clinical Trials and Clinical Research with a theme of Integrating precision in methodology, design and analysis of advanced clinical trials scheduled to be held on October 22-23, 2019 in Rome, Italy This Clinical Trials 2019 hosts a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions, and Career development programs. It strives to bring all the Researchers, Students and Business people under one roof to share their ideas and conduct collaborated research. Clinical Trials focuses on the importance to understand drugs and how they can affect human physiology. It is with the better understanding of one can know the effect of the drug what it is making on the human being and is there any change required for the betterment. 

 

Track 1: Clinical Research & Clinical Trials: Academic Perspective

The objective of Clinical trials is to decide the security and adequacy of the medication in the member. Investigating routes for an agreeable life for individuals with constant ailment. Clinical Trials are led by a group of analyst which incorporates a specialist, social laborers, Contract inquire about Organizations and other human services experts. Clinical Trials done in the United States must be affirmed and checked by the Institutional Review Board [IRB]

Clinical Trial Conferences | Clinical Trial Events | Drug Design Conferences | Clinical Trial Congress | Clinical Trial Meetings | Medical Conferences | Medical Research Conferences | Clinical Research Conferences

Track 2: Clinical Trial Phases

This session incorporates the exchange about the different stages in the Clinical Trials for instance an examination target would be discovered whether the medication is hurtful to the living tissue. Additionally, it might plan to locate the substance cosmetics of the medication. Along these lines this is directed just when there is a legitimate motivation to trust that the treatment would demonstrate change in the patient.

Clinical Trial Conferences | Clinical Trial Events | Drug Design Conferences | Clinical Trial Congress | Clinical Trial Meetings | Medical Conferences | Medical Research Conferences | Clinical Research Conferences

Track 3: Pharmacogenomics

Pharmacogenomics is the investigation of how qualities influence a man's reaction to drugs. This generally new field joins pharmacology (the study of medications) and genomics (the investigation of qualities and their capacities) to create powerful, safe prescriptions and measurements that will be custom fitted to a man's hereditary cosmetics.

Clinical Trial Conferences | Clinical Trial Events | Drug Design Conferences | Clinical Trial Congress | Clinical Trial Meetings | Medical Conferences | Medical Research Conferences | Clinical Research Conferences

Track 4: Patient-Centric Clinical Trials

Human Clinical Trials of new sub-atomic elements in grown-up sound volunteer which prescribes an institutionalized method by which the MSRD can be chosen. The reason for this procedure is to guarantee the security of the human volunteers and furthermore to build up a reliable phrasing for examining the beginning dosage, give regular change variables to inferring a human proportional measurements (HED), and depict a technique for choosing the MRSD for grown-up sound volunteers, paying little mind to the anticipated clinical utilize.

Clinical Trial Conferences | Clinical Trial Events | Drug Design Conferences | Clinical Trial Congress | Clinical Trial Meetings | Medical Conferences | Medical Research Conferences | Clinical Research Conferences

Track 5: Pharmacovigilance & Drug Safety

The pharmacological science identifying with the identification, evaluation, checking the wellbeing of the pharmaceutical medication or therapeutic gadget, and aversion of unfriendly impacts with other pharmaceutical items in the wake of being discharged from the market is an essential piece of pharmacovigilance. Pharmacovigilance utilizes different ways to deal with screen medication and gadget wellbeing, including unconstrained revealing databases, medicine occasion checking, electronic wellbeing records, tolerant vaults, and record linkage between wellbeing databases. The information is evaluated to feature potential security worries in a procedure known as information mining.

Clinical Trial Conferences | Clinical Trial Events | Drug Design Conferences | Clinical Trial Congress | Clinical Trial Meetings | Medical Conferences | Medical Research Conferences | Clinical Research Conferences

Track 6: Clinical Trials on different Diseases

Clinical Trials for different diseases and messes are coordinated for evaluating somewhere around one interventions (for example, drugs, therapeutic devices, approaches to manage medical procedure or radiation treatment ) for treating a contamination, issue, or condition and besides finding ways to deal with keep the basic change or rehash of an ailment or condition. These can consolidate arrangements, antibodies, or lifestyle changes, among various approach. A couple of instances of the contaminations/issue for which clinical preliminaries coordinating are cardiovascular, digestive system, respiratory structure diseases and other parasitic, viral, bacterial and infectious ailments. Likewise, clinical trials on practices, mental, rest and dietary issues.

Clinical Trial Conferences | Clinical Trial Events | Drug Design Conferences | Clinical Trial Congress | Clinical Trial Meetings | Medical Conferences | Medical Research Conferences | Clinical Research Conferences

Track 7: Nano technology in clinical trials

The use of nanotechnology to remedy consolidates the usage of unequivocally constructed materials to make novel medications and devices that may decrease peril and what's more redesign the practicality and transport of meds. As needs be, the utilization of nanotechnology to infection can provoke numerous advances in the expectation, disclosure, and treatment of threat. The key nanotechnology-based development drugs have passed. Of late, the U.S. Sustenance and Drug Administration (FDA) has embraced different Investigational New Drug (IND) applications for Nano-definitions, engaging clinical preliminaries for chest, gynecological, solid tumour, lung, mesenchymal tissue, lymphoma, central tangible framework and urogenitory malady meds. The bigger piece of these preliminaries repurpose the already embraced developments depicted beforehand.

 Clinical Trial Conferences | Clinical Trial Events | Drug Design Conferences | Clinical Trial Congress | Clinical Trial Meetings | Medical Conferences | Medical Research Conferences | Clinical Research Conferences

Track 8: Clinical trials in Oncology

Disease rate increments as the populace ages. In an investigation of 23 oncology contemplates and 6000 patients, a portion of the hindrances to taking part in clinical preliminaries were dread of decreased quality life, additionally a worry that trial medication may not be the right choice. A continuous symptomatic investigation is assessing the precision of 3D ultrasounds in correlation with MRI and last histology to identify myometrial intrusion in endometrial growth.

Clinical Trial Conferences | Clinical Trial Events | Drug Design Conferences | Clinical Trial Congress | Clinical Trial Meetings | Medical Conferences | Medical Research Conferences | Clinical Research Conferences

Track 9: Bioinformatics in Clinical Research

Bioinformatics is an interdisciplinary subject that causes us in gathering, investigating and imitating the natural information in Digital way and creating programming apparatuses for the organic practices. With the utilization of Bioinformatics instruments it turns out to be anything but difficult to diminish the work related with the Clinical Trials and Research. Clinical bioinformatics should focus on Relating clinical practice and biochemical/genetic benchmarks. The typical issue in clinical bioinformatics is relating miniaturized scale discoveries decided from test data (microarray data, Serial Analysis of Gene Expression, linkage examination, structure examination strategies as mass spectroscopy) and large scale properties, for instance, ailment signs and metabolic pathways. At the event, there are not by any stretch of the imagination any data that could fulfill the necessities on the two scales: there are quality plan and remark data related to smaller scale ponders on the one side, and on the other there are clinical surveys depicting the discoveries on the full scale.

Clinical Trial Conferences | Clinical Trial Events | Drug Design Conferences | Clinical Trial Congress | Clinical Trial Meetings | Medical Conferences | Medical Research Conferences | Clinical Research Conferences

Track 10: Clinical Data Management

Clinical Data Management is the strategy of aggregation, cleaning, coordination and organization of subject data in consistence with regulatory rules. It is a fundamental stage in clinical research, which prompts period of high bore, tried and true, and quantifiably stable data from clinical preliminaries, this has been empowered by the use of programming applications that keep up an audit trail and give basic distinctive evidence and assurance of data differences. CDM furthermore supports the immediate, organization and examination of concentrates over the scope of clinical research. An authoritative target of CDM is to ensure that data reinforce ends drawn from research. Achieving this target guarantees general prosperity and trust in publicized therapeutics.

Clinical Trial Conferences | Clinical Trial Events | Drug Design Conferences | Clinical Trial Congress | Clinical Trial Meetings | Medical Conferences | Medical Research Conferences | Clinical Research Conferences

Market Reseach :

The global clinical trials market is expected to reach $65.2 billion by 2025, according to a new report by Grand View Research. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and boosting demand for CROs to conduct clinical trials.

Growing prevalence of disease and incidence of new disease is expected to give further boost to the clinical trial market. Worldwide population has varied disease profile with emerging countries having the most diverse disease profile. This is expected to boost the clinical trial of new or rare disease which otherwise would not have found any sponsors. More number of patients having a specific disease would act as a stimulus for biopharmaceutical companies to invest more in clinical trials for a disease segment.

Key findings from the report suggest:

  • The global clinical trials market witnessed a lucrative growth in 2016 and is expected to grow at a CAGR of over 5.5% from 2017 to 2025.
  • The market is expected to be dominated by phase III as of 2016, with phase I anticipated to witness the fastest growth.
  • Increasing innovation and evolution of treatment is predicted to contribute toward growth of the expanded access trials segment.
  • Based on indication, the oncology segment is anticipated to witness the fastest growth. According to various sources, more than $38.0 billion is currently being spent by the healthcare industry towards preclinical and clinical development of oncology therapy products.
  • North America dominated the overall market in terms of revenue share in 2015 owing to the presence of big outsourcing firms and increasing R&D in the region.
  • Key players including Quintiles IMS, Paraxel International Corporation, Charles River Laboratories, ICON, SGS, among others, dominate the global clinical trials market while representing maximum volume in 2016.

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the latest trends and opportunities in each of the sub segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the clinical trials market on the basis of phase, study design, indication, and region:

Phase Outlook (Revenue, USD Million; 2014 - 2025)

Phase I, Phase II, Phase III, Phase IV

Study Design Outlook (Revenue, USD Million; 2014 - 2025)

Interventional, Observational, Expanded Access

Indication Outlook (Revenue, USD Million; 2014 - 2025)

Autoimmune/inflammation, Pain management, Oncology, CNS condition, Diabetes, Obesity, Cardiovascular

Regional Outlook (Revenue, USD Million; 2014 - 2025)

North America, U.S., Canada, Europe, Germany, UK, Asia Pacific, China, Japan, Latin America, Mexico, Brazil, South Africa

Clinical Trials Associations in the World:

  • Pan Asian Clinical Research Association
  • Society for clinical trials
  • Association Clinical Research Professionals
  • Society of Clinical Research Associates
  • International Clinical Trials Association
  • Clinical Research Society
  • European Society of Clinical pharmacy
  • European Clinical Research Infrastructure Network
  • European CRO Foundation
  • Association of Clinical Research Organizations
  • The European Association for Clinical Pharmacology and Therapeutics
  • Society for Clinical Data Management
  • The European Association for Clinical Pharmacology and Therapeutics (EACPT)
  • Association of Clinical Research Organization
  • American Federation of Medical Research
  • Indian Association for Statistics in Clinical Trials
  • Institute of Clinical Research
  • International Federation of Pharmaceutical Manufacturers Association
  • Drug Information Association
  • Clinical Research Malaysia
  • European Centre for Clinical Research Training
  • Clinical and Contract Research Association

 

  • Clinical manufacturing and packaging
  • Clinical Trials in Oncology
  • Bioinformatics in Clinical Research
  • Clinical Data Management
  • Clinical Research & Clinical Trials: Academic Perspective
  • Pharmacogenomics
  • Patient-Centric Clinical Trials
  • Pharmacovigilance & Drug Safety
  • Clinical Trials on different Diseases
  • Nano technology in clinical trials

3 Organizing Committee Members